YOLT-203

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameYOLT-203
Drug Alias NameYOLT-203
ClassificationCell and gene therapy > Gene therapy > LNPCell and gene therapy > Gene therapy > Gene editing > CRISPR > CRISPR-Cas12
Mechanisms of ActionHydroxyacid oxidase 1 modulators
TargetsHydroxyacid oxidase 1
Therapy Area/IndicationsPrimary Hyperoxaluria Type 1HyperuricemiaHyperoxaluria, Primary +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Yaotang Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesYolTech Therapeutics Co LtdRenji Hospital Affiliated To Shanghai Jiaotong University School Of MedicineGuangzhou Women And Children'S Medical Center +[4] 
Inactive CompaniesN/A
Active IndicationsPrimary Hyperoxaluria Type 1HyperuricemiaHyperoxaluria, Primary +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A